Neurodevelopmental disorders (NDDs) impair the normal development and functioning of the brain, leading to a wide spectrum of cognitive, motor and behavioral deficits. Approximately 15% are monogenic, yet 90% of the patients still lack precise, mechanism-based treatments. This gap underscores an urgent need to deeper mechanistic investigation and the development of personalized therapies. Clinical studies have identified pathogenic variants in genes encoding subunits of the Mediator complex — a central regulator of transcription— liking them to several monogenic NDDs with overlapping clinical features. These conditions are collectively termed “Neuro-MEDopathies”, reflecting their shared molecular basis in Mediator dysfunction. Among these, MED27 has emerged as a key gene associated with a novel autosomal recessive NDD characterized by intellectual disability and cataracts, with cerebellar atrophy being the most consistent feature across affected patients. This convergence on cerebellar pathology suggests that MED27-dependet transcriptional regulation is especially critical for cerebellar development and function.

The CUHK research team, led by Dr. Linda Shen GU, investigated the pathogenic mechanism by generating patient-specific MED27-mutant stem cell models and transgenic mice with Med27 loss-of-function, successfully recapitulating core patient phenotypes. Using these complementary models, they observed progressive cerebellar atrophy and motor deficits that mirror clinical presentations. Mechanistically, mutant MED27 destabilizes the Mediator complex, weakens its occupancy on chromatin, and alters 3D chromatin architecture. These changes converge to dampen the expression of key transcription factors for early neurogenesis and cerebellar development, providing a direct molecular link between MED27 dysfunction and the observed neurodevelopmental defects.

This work has been published in the scientific journal Advanced Science and been selected as the inside cover story. The full article is available at: https://doi.org/10.1002/advs.202505535.

During early neural differentiation, CUT&Tag-seq and proteomics analyses revealed that patient-specific mutations weakened MED27’s interactions with neighboring Mediator subunits and impaired the complex’s binding to chromatin. These defects suggest a compromised assembly and stability of the Mediator complex at target regulatory elements. By integrating transcriptomic data with Hi-C, the study further demonstrated that the immediate early genes (IEGs) EGR1 and FOS are direct downstream targets of MED27. Disrupted chromatin architecture at their loci, coupled with reduced Mediator occupancy, correlates with attenuated IEG activation — implicating MED27 as a critical regulator of early neurogenic transcriptional programs.

They also established multiple Med27 knockout (KO) mouse models to dissect tissue-specific requirements. Global knockout resulted in early embryonic lethality, indicating an essential role for Med27 in early development. CNS-specific KO caused perinatal death accompanied by cerebellar agenesis, while cerebellum-specific KO led to progressive cerebellar atrophy and motor deficits, faithfully recapitulating the patient phenotype. Histopathology analyses revealed a pronounced loss of Purkinje cells (PCs) and defects in dendritic maturation. At the molecular level, single-cell spatial transcriptomics identified Lhx1 as a direct downstream target of Med27. Notably, Lhx1 is a well-established transcription factor required for embryonic brain development and Purkinje cell differentiation, linking Med27 dysfunction to disrupted cerebellar lineage specification and maturation.

This study elucidates how patient-specific MED27 mutations impair the transcription of key genes during neurodevelopment. The findings not only establish multiple robust preclinical models — providing a strong experimental and conceptual foundation for future therapies — but also offer new insights into the functions of other Mediator subunits in brain development. By linking Mediator integrity to chromatin architecture and lineage-defining transcriptional programs, the work highlights feasible nodes for therapeutic intervention and sets the stage for cross-disorder comparisons among “Neuro-MEDopathies”.

This research was supported by the Research Grants Council of Hong Kong, the National Natural Science Foundation of China, and the Gerald Choa Neuroscience Institute at The Chinese University of Hong Kong. Ph.D. students Nuermila YILIYAER, Xiaocheng LI and Tianyu GUO are co–first authors. Additionally, the study benefited greatly from the expertise and support of the teams led by Prof. Huating WANG and Prof. Kin Ming KWAN at CUHK, as well as Assistant Prof. Yong LEI at CUHK (Shenzhen).